Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia

Asim Jamal Shaikh, Samira Ahmed Bawany, Nehal Masood, Ausaf Ahmed Khan, Ahmed Nadeem Abbasi, Syed Najeeb Niamutullah, Adnan Zaidi, Salman Adil, Shiyam Kumar

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Febrile neutropenia (FN) and myelosupression remain a challenging on-cologic medical emergency and dose limiting toxicity associated with chemotherapy for cancers. Various factors are known to affect the outcomes for patients diagnosed with FN. Electrolyte abnormalities have commonly been observed, but the real incidence and their impact has been only scarcely studied in literature. Methods: This was a prospective, observational study. A total of two hundred and fifteen (215) patients admitted between January 2007 and August 2008 were included. Analysis of data was made using SPSS version 16.0. Toxicity profile was graded according to CTC version 3.0. Results: Almost equal number of FN was observed in both solid tumors and hematological cancers with almost equal gender distribution. Of all 83.5% patients demonstrated some electrolyte abnormalities. All grades combined, hypokalemia was seen in 48% of patients, with 51.4% having grade I, 33.3% grade III and 15.2% G IV (life threatening) hypokalemia. Hypo-natremia of all grades was seen in 67.9% patients, of them 60.3% had Grade I, 33.3% grade III and 0.7% patients had grade IV hyponatremia. Hypomagnesaemia (70 patients assessed) was seen in 54.3% patient, 94.7% having grade I decline. Average length of stay for patients who received IV electrolyte replacement was 6.3 days compared to 4.9 days in those who did not. Out of 90 patients who required special care unit 75 had electrolyte abnormalities, of 15 patients who expired 13 had electrolyte abnormalities Conclusion: This analysis, which is first of its kind, suggests that decline in electrolyte levels is frequently observed in patients presenting with FN. These abnormalities can have independent negative impact on the outcome for such patients. Special attention should be paid to electrolyte imbalance right from the outset.

Original languageEnglish
Pages (from-to)62-66
Number of pages5
JournalJournal of Cancer
Volume2
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Chemotherapy-Induced Febrile Neutropenia
Electrolytes
Incidence
Febrile Neutropenia
Hypokalemia
Neoplasms

Keywords

  • Baseline electrolyte abnormalities
  • Febrile neutropenia
  • Myelosupression

ASJC Scopus subject areas

  • Oncology

Cite this

Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia. / Shaikh, Asim Jamal; Bawany, Samira Ahmed; Masood, Nehal; Khan, Ausaf Ahmed; Abbasi, Ahmed Nadeem; Niamutullah, Syed Najeeb; Zaidi, Adnan; Adil, Salman; Kumar, Shiyam.

In: Journal of Cancer, Vol. 2, No. 1, 2011, p. 62-66.

Research output: Contribution to journalArticle

Shaikh, AJ, Bawany, SA, Masood, N, Khan, AA, Abbasi, AN, Niamutullah, SN, Zaidi, A, Adil, S & Kumar, S 2011, 'Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia', Journal of Cancer, vol. 2, no. 1, pp. 62-66. https://doi.org/10.7150/jca.2.62
Shaikh, Asim Jamal ; Bawany, Samira Ahmed ; Masood, Nehal ; Khan, Ausaf Ahmed ; Abbasi, Ahmed Nadeem ; Niamutullah, Syed Najeeb ; Zaidi, Adnan ; Adil, Salman ; Kumar, Shiyam. / Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia. In: Journal of Cancer. 2011 ; Vol. 2, No. 1. pp. 62-66.
@article{4068b3c2a0dd4755b4bcbe578d0f0ae8,
title = "Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia",
abstract = "Background: Febrile neutropenia (FN) and myelosupression remain a challenging on-cologic medical emergency and dose limiting toxicity associated with chemotherapy for cancers. Various factors are known to affect the outcomes for patients diagnosed with FN. Electrolyte abnormalities have commonly been observed, but the real incidence and their impact has been only scarcely studied in literature. Methods: This was a prospective, observational study. A total of two hundred and fifteen (215) patients admitted between January 2007 and August 2008 were included. Analysis of data was made using SPSS version 16.0. Toxicity profile was graded according to CTC version 3.0. Results: Almost equal number of FN was observed in both solid tumors and hematological cancers with almost equal gender distribution. Of all 83.5{\%} patients demonstrated some electrolyte abnormalities. All grades combined, hypokalemia was seen in 48{\%} of patients, with 51.4{\%} having grade I, 33.3{\%} grade III and 15.2{\%} G IV (life threatening) hypokalemia. Hypo-natremia of all grades was seen in 67.9{\%} patients, of them 60.3{\%} had Grade I, 33.3{\%} grade III and 0.7{\%} patients had grade IV hyponatremia. Hypomagnesaemia (70 patients assessed) was seen in 54.3{\%} patient, 94.7{\%} having grade I decline. Average length of stay for patients who received IV electrolyte replacement was 6.3 days compared to 4.9 days in those who did not. Out of 90 patients who required special care unit 75 had electrolyte abnormalities, of 15 patients who expired 13 had electrolyte abnormalities Conclusion: This analysis, which is first of its kind, suggests that decline in electrolyte levels is frequently observed in patients presenting with FN. These abnormalities can have independent negative impact on the outcome for such patients. Special attention should be paid to electrolyte imbalance right from the outset.",
keywords = "Baseline electrolyte abnormalities, Febrile neutropenia, Myelosupression",
author = "Shaikh, {Asim Jamal} and Bawany, {Samira Ahmed} and Nehal Masood and Khan, {Ausaf Ahmed} and Abbasi, {Ahmed Nadeem} and Niamutullah, {Syed Najeeb} and Adnan Zaidi and Salman Adil and Shiyam Kumar",
year = "2011",
doi = "10.7150/jca.2.62",
language = "English",
volume = "2",
pages = "62--66",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "1",

}

TY - JOUR

T1 - Incidence and impact of baseline electrolyte abnormalities in patients admitted with chemotherapy induced febrile neutropenia

AU - Shaikh, Asim Jamal

AU - Bawany, Samira Ahmed

AU - Masood, Nehal

AU - Khan, Ausaf Ahmed

AU - Abbasi, Ahmed Nadeem

AU - Niamutullah, Syed Najeeb

AU - Zaidi, Adnan

AU - Adil, Salman

AU - Kumar, Shiyam

PY - 2011

Y1 - 2011

N2 - Background: Febrile neutropenia (FN) and myelosupression remain a challenging on-cologic medical emergency and dose limiting toxicity associated with chemotherapy for cancers. Various factors are known to affect the outcomes for patients diagnosed with FN. Electrolyte abnormalities have commonly been observed, but the real incidence and their impact has been only scarcely studied in literature. Methods: This was a prospective, observational study. A total of two hundred and fifteen (215) patients admitted between January 2007 and August 2008 were included. Analysis of data was made using SPSS version 16.0. Toxicity profile was graded according to CTC version 3.0. Results: Almost equal number of FN was observed in both solid tumors and hematological cancers with almost equal gender distribution. Of all 83.5% patients demonstrated some electrolyte abnormalities. All grades combined, hypokalemia was seen in 48% of patients, with 51.4% having grade I, 33.3% grade III and 15.2% G IV (life threatening) hypokalemia. Hypo-natremia of all grades was seen in 67.9% patients, of them 60.3% had Grade I, 33.3% grade III and 0.7% patients had grade IV hyponatremia. Hypomagnesaemia (70 patients assessed) was seen in 54.3% patient, 94.7% having grade I decline. Average length of stay for patients who received IV electrolyte replacement was 6.3 days compared to 4.9 days in those who did not. Out of 90 patients who required special care unit 75 had electrolyte abnormalities, of 15 patients who expired 13 had electrolyte abnormalities Conclusion: This analysis, which is first of its kind, suggests that decline in electrolyte levels is frequently observed in patients presenting with FN. These abnormalities can have independent negative impact on the outcome for such patients. Special attention should be paid to electrolyte imbalance right from the outset.

AB - Background: Febrile neutropenia (FN) and myelosupression remain a challenging on-cologic medical emergency and dose limiting toxicity associated with chemotherapy for cancers. Various factors are known to affect the outcomes for patients diagnosed with FN. Electrolyte abnormalities have commonly been observed, but the real incidence and their impact has been only scarcely studied in literature. Methods: This was a prospective, observational study. A total of two hundred and fifteen (215) patients admitted between January 2007 and August 2008 were included. Analysis of data was made using SPSS version 16.0. Toxicity profile was graded according to CTC version 3.0. Results: Almost equal number of FN was observed in both solid tumors and hematological cancers with almost equal gender distribution. Of all 83.5% patients demonstrated some electrolyte abnormalities. All grades combined, hypokalemia was seen in 48% of patients, with 51.4% having grade I, 33.3% grade III and 15.2% G IV (life threatening) hypokalemia. Hypo-natremia of all grades was seen in 67.9% patients, of them 60.3% had Grade I, 33.3% grade III and 0.7% patients had grade IV hyponatremia. Hypomagnesaemia (70 patients assessed) was seen in 54.3% patient, 94.7% having grade I decline. Average length of stay for patients who received IV electrolyte replacement was 6.3 days compared to 4.9 days in those who did not. Out of 90 patients who required special care unit 75 had electrolyte abnormalities, of 15 patients who expired 13 had electrolyte abnormalities Conclusion: This analysis, which is first of its kind, suggests that decline in electrolyte levels is frequently observed in patients presenting with FN. These abnormalities can have independent negative impact on the outcome for such patients. Special attention should be paid to electrolyte imbalance right from the outset.

KW - Baseline electrolyte abnormalities

KW - Febrile neutropenia

KW - Myelosupression

UR - http://www.scopus.com/inward/record.url?scp=84873238412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873238412&partnerID=8YFLogxK

U2 - 10.7150/jca.2.62

DO - 10.7150/jca.2.62

M3 - Article

VL - 2

SP - 62

EP - 66

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 1

ER -